Treatment of seizures in acute intermittent porphyria: safety and efficacy of gabapentin
- PMID: 9808120
- DOI: 10.1016/s1059-1311(05)80013-5
Treatment of seizures in acute intermittent porphyria: safety and efficacy of gabapentin
Abstract
Treatment of seizures in acute intermittent porphyria represents a therapeutic dilemma. Patients needing chronic therapy often experience acute porphyric attacks due to increased hepatic metabolism induced by the antiepileptic drugs themselves. Gabapentin is a new antiepileptic drug not appreciably metabolized by the liver in humans, and it appears to be safe and effective in the maintenance therapy of epilepsy in these patients. We report a patient affected by partial and generalized seizures in the course of acute intermittent porphyria, who was safely and successfully treated with gabapentin.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
